Search Page

1

Cite

Share

An analysis of 112 acute porphyric attacks in Cape Town, South Africa: Evidence that acute intermittent porphyria and variegate porphyria differ in susceptibility and severity.

Hift RJ, Meissner PN. Hift RJ, et al. Among authors: meissner pn. Medicine (Baltimore). 2005 Jan;84(1):48-60. doi: 10.1097/01.md.0000152454.56435.f3. Medicine (Baltimore). 2005. PMID: 15643299 Free article.

Cite

Share

2

Cite

Share

Acute intermittent porphyria presenting as progressive muscular atrophy in a young black man.

Albertyn CH, Sonderup M, Bryer A, Corrigall A, Meissner P, Heckmann JM. Albertyn CH, et al. S Afr Med J. 2014 Apr;104(4):283-5. doi: 10.7196/samj.7785. S Afr Med J. 2014. PMID: 25118551

Cite

Share

3

Cite

Share

Molecular characterisation of acute intermittent porphyria in a cohort of South African patients and kinetic analysis of two expressed mutants.

Fortgens P, Pienaar E, Corrigall A, Sonderup M, Spearman CW, Meissner P. Fortgens P, et al. J Clin Pathol. 2017 Jun;70(6):515-520. doi: 10.1136/jclinpath-2016-203907. Epub 2016 Nov 14. J Clin Pathol. 2017. PMID: 27849156

Cite

Share

4

Cite

Share

Allosteric inhibition of human lymphoblast and purified porphobilinogen deaminase by protoporphyrinogen and coproporphyrinogen. A possible mechanism for the acute attack of variegate porphyria.

Meissner P, Adams P, Kirsch R. Meissner P, et al. J Clin Invest. 1993 Apr;91(4):1436-44. doi: 10.1172/JCI116348. J Clin Invest. 1993. PMID: 7682572 Free PMC article.

Cite

Share

5

Cite

Share

Plasma fluorescence scanning and fecal porphyrin analysis for the diagnosis of variegate porphyria: precise determination of sensitivity and specificity with detection of protoporphyrinogen oxidase mutations as a reference standard.

Hift RJ, Davidson BP, van der Hooft C, Meissner DM, Meissner PN. Hift RJ, et al. Among authors: meissner pn, meissner dm. Clin Chem. 2004 May;50(5):915-23. doi: 10.1373/clinchem.2003.025213. Epub 2004 Feb 19. Clin Chem. 2004. PMID: 14976149

Cite

Share

6

Cite

Share

A review of the clinical presentation, natural history and inheritance of variegate porphyria: its implausibility as the source of the 'Royal Malady'.

Hift RJ, Peters TJ, Meissner PN. Hift RJ, et al. Among authors: meissner pn. J Clin Pathol. 2012 Mar;65(3):200-5. doi: 10.1136/jclinpath-2011-200276. Epub 2011 Nov 2. J Clin Pathol. 2012. PMID: 22049218 Review.

Cite

Share

7

Cite

Share

Fifty years of porphyria at the University of Cape Town.

Meissner PN, Corrigall AV, Hift RJ. Meissner PN, et al. S Afr Med J. 2012 Mar 2;102(6):422-6. doi: 10.7196/samj.5710. S Afr Med J. 2012. PMID: 22668925

Cite

Share

8

Cite

Share

Mitochondrial targeting of human protoporphyrinogen oxidase.

Davids LM, Corrigall AV, Meissner PN. Davids LM, et al. Among authors: meissner pn. Cell Biol Int. 2006 May;30(5):416-26. doi: 10.1016/j.cellbi.2006.02.001. Epub 2006 Mar 6. Cell Biol Int. 2006. PMID: 16621625

Cite

Share

9

Cite

Share

Propofol as an i.v. anaesthetic induction agent in variegate porphyria.

Meissner PN, Harrison GG, Hift RJ. Meissner PN, et al. Br J Anaesth. 1991 Jan;66(1):60-5. doi: 10.1093/bja/66.1.60. Br J Anaesth. 1991. PMID: 1997060 Free article. Clinical Trial.

Cite

Share

10

Cite

Share

Safety of vancomycin in acute porphyria.

Hift R, Sohnius U, Meissner PN. Hift R, et al. Among authors: meissner pn. Br J Clin Pharmacol. 1990 Feb;29(2):273-5. doi: 10.1111/j.1365-2125.1990.tb03634.x. Br J Clin Pharmacol. 1990. PMID: 2306423 Free PMC article.

Cite

Share